Диссертация (1141076), страница 14
Текст из файла (страница 14)
Culha // Journal of Biomedical Optics. –2015. – 20.4: P. 47002–9.91.Mo J. High wavenumber Raman spectroscopy for in vivo detection of cervicaldysplasia / J Mo, W Zheng, JJ Low et al. // Anal Chem. – 2009. – Nov1;81(21): P. 8908–15.92.Molckovsky A. Diagnostic potential of near-infrared Raman spectroscopy inthe colon: differentiating adenomatous from hyperplastic polyps / AMolckovsky, LM Song, MG Shim et al.
// GastrointestEndosc. – 2003. – Mar;57(3):P. 396–402.93.Morrison C.J. Matrix metalloproteinase proteomics: substrates, targets, andtherapy / C. J. Morrison, G. S. Butler, D. Rodrıguez et al. // Curr. Opin. CellBiol Vol. 21. – 2009. – P. 1–9.94.Movasaghi Z. Raman Spectroscopy of Biological Tissues / Z Movasaghi, SRehman, U Ihtesham et al. // Applied Spectroscopy Reviews. – 2007. – 42: P.493–541.95.Naglic P. Raman spectroscopy for medical diagnostics / P. Naglic // Universityof Ljubjana Faculty of Mathematics and Physics.
– 2012. – P. 6–9.96. Ning H1, Shao QQ, Ding KJ, Gao DX, Lu QL, Cao QW, Niu ZH, Fu Q, ZhangCH, Qu X, Lü JJ. Tumor-infiltrating regulatory T cells are positively correlatedwith angiogenic status in renal cell carcinoma //(Chin Med J (Engl). 2012Jun;125(12): P. 2120-5.97.Papadopoulos I. Correlation between DNA ploidy, proliferation marker ki-67and early tumor progression in renal cell carcinoma. A prospective study / I.Paradopoulos, K.
Weichert-Jacobsen, H.H. Waker et al. // Eur. Urol Vol.31. –1997. – P. 49–53.98.Patard JJ. Correlation between symptom graduation, tumor characteristics andsurvival in renal cell carcinoma / JJ Patard, E Leray, A. Rodriguez et al. // EurUrol. – 2003. – Aug; 44(2): P. 226–32.9699. Pencel I. Clinical instrumentation and applications of Rman spectroscopy / I.Pencel, A Mhadevan-Jansen // Chem. Soc. Rev.
– 2016. – 45: P. 1–7.100.Phuoc N.B. Immunohistochemical analysis with multiple antibodies insearch of prognostic markers for clear cell renal carcinoma / N.B. Phuoc, H.Ehara, T. Goton et al. // Urology Vol. 69. – 2007. – P. 843–48.101.Qiao Z.-K. Expression of tissue levels of matrix metalloproteinases andtissue inhibitors of metalloproteinases in renal cell carcinoma / Z.-K. Qiao, Y.-I.Li, H.-T. Lu et al. // W. J.
Surg. Oncol. – 2013. – Vol. 11. – №1. – P. 1–6.102. Rankin S.C. Spiral CT in the diagnosis of renalmasses / S.C. Rankin, J.A.B.Webb, R.H. Raznek // BJ.U.Int. – 2000. – Vol. 26. – Supl.l. – P. 48–57.103. Raman C.V., Krishnan K.S. A new type of secondary radiation // Nature/ 121. – 1928. P. 501-502.104. Robichaux-Viehoever A. Characterization of Raman spectra measured invivo for the detection of cervical dysplasia / A. Robichaux-Viehoever, E.Kanter, H. Shappell // ApplSpectrosc.
– 2007. – Sep;61(9): P. 986–93.105. Ryu K. H., Im C. M., Kim M.K. et al. Inflammatory myofibroblastic tumorof the kidney misdiagnosed as renal cell carcinoma // J. Korean. Med. Sci. –2010. – Vol. 25. №2. P. 330-332.106. Sangoi AR. The use of immunohistochemistry in the diagnosis of metastaticclear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma,and CD10 / AR Sangoi, J Karamchandani, J Kim //AdvAnatPathol. – 2010.
–Nov;17(6): P.377–93.107. Sato A. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reducescell invasion in renal cell carcinoma / A. Sato, H. Nagase, D. Obinata et al. //Int. J. Oncol Vol. 43, 35.– 2013. – P. 1441–1446.108. Savitzky A. Smoothing and differentiation of data by simplified leastsquares procedure / A. Savitzky, M.J.E. Golay // Analytical Chemistry. – 1964.– 36: P.1627 – 1639.97109.
Seaman E. Association of radionuclide bone scan and serum alkalinephosphatase in patients with metastatic renal cell carcinoma / E. Seaman //Urology Vol. 48. – 1996. – P. 692–695.110. Schlomer B, Figenshau RS, Yan Y, et al. Pathological features ofrenalneoplasms classified by size and symptomatology. J Urol 2006; 176(4): P.1317–20.111. Stewart S. Distinguishing between renal oncocytoma and hromophobe renalcell carcinoma using Raman molecular imaging / S.
Stewart, H. Kirschner, P.J.Treado, R. Priore // J. Raman Spectrosc. – 2014. – 45: P. 274–280.112. Teh SK. Diagnostic potential of near-infrared Raman spectroscopy in thestomach: differentiating dysplasia from normal tissue / SK Teh, W Zheng, KYHo // Br J Cancer. – 2008. – Jan 29; 98(2):457–65.113. Tickoo SK.
Ultrastructural observations on mitochondria and microvesiclesin renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilicvariant of conventional (clear cell) renal cell carcinoma / SK Tickoo, MW Lee,JN Eble // Am J SurgPathol. – 2000. – Sep;24(9): 1247–56.114. Tynski Z. Renal pseudotumors / Z. Tynski, GT. MacLennan // J Urol. –2005.
– 173: P.600.115. V. M. Villaamil, G. A. Gallego, I. S. Caínzos et al. Relevant networksinvolvingcarcinoma//thep53signallingpathwayJ.Biomed.Int.inrenalSci.cell–2011. – Vol.7, №4. – P. 273–282.116. Wenjuan Y. Clinicopathological, genetic, ultrastructural characterizationsand prognostic factors of papillary renal cell carcinoma: New diagnostic andprognostic information / Y Wenjuan, B Wei Zhang, YanxiaJianga et al. //ActaHistochemica. – 2013. – 115: P. 452–459.117.
Yamaguchi T. Chromophobe renal cell carcinoma, oncocytic variant:Cytological and ultrastructural observations / T. Yamaguchi, E.Hirota, N.Kuroda // J Cytol. – 2015. – Jul–Sep; 32(3): 184–187.98118. Zheng F. Sensitivity map of laser tweezers Raman spectroscopy for singlecell analysis of colorectal cancer / F Zheng, Y Qin, K Chen // J Biomed Opt. –2007. – May–Jun; 12(3) :034002.119. Zigeuner R. Value of p53 as a prognostic marker in histologic subtypes ofrenal cell carcinomas: a systematic analysis of primary and metastatic tumortissue / R. Zigeuner, M. Ratschek, P.
Rehak et al. // Urology. – 2004. – 63: P.651.120. Zolota V., Tsamandas A.C., Melachrinou M. et al. Expression of CD44protein in renal cell carcinomas: association with p53 expression. Urol. Oncol.2002; №7(1): P. 13‐17.99.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
